GT Biopharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GT Biopharma and other ETFs, options, and stocks.About GTBP
GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of the immuno-oncology therapeutic products based proprietary TriKE NK cell engager platform. The TriKE platform is designed to harness and enhance the cancer killing abilities of a patient's immune system natural killer cells (NK cells).
GTBP Key Statistics
Stock Snapshot
As of today, GT Biopharma(GTBP) shares are valued at $0.45. The company's market cap stands at 14M, with a P/E ratio of -0.03.
During the trading session on 2026-04-04, GT Biopharma(GTBP) shares reached a daily high of $0.45 and a low of $0.40. At a current price of $0.45, the stock is +12.4% higher than the low and still -0.0% under the high.
Trading volume for GT Biopharma(GTBP) stock has reached 407.56K, versus its average volume of 722.98K.
The stock's 52-week range extends from a low of $0.39 to a high of $3.85.
The stock's 52-week range extends from a low of $0.39 to a high of $3.85.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.